Asia Pacific Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type, Treatment Type, Infection Severity, and End User

Description

List of Tables

The Asia Pacific diabetic foot ulcer market was valued at US$ 1,455.82 million in 2022 and is expected to reach US$ 2,472.61 million by 2030; it is estimated to grow at a CAGR of 6.8% from 2022 to 2030.

Surge In Geriatric Population Fuels the Asia Pacific Diabetic Foot Ulcer Market.

Age-associated diabetes is common globally. The deficiency of insulin secretion develops with age and the insulin resistance increases due to a change in body composition and sarcopenia. According to Endocrine Society, an estimated 33% of adults aged 65 or older have diabetes. Additionally, the population is more at risk of developing diabetes-related complications. According to the Global Ageing Survey 2019, the pace of aging (i.e., people aged 60 and above) by 2050 will be nearly a quarter or more in most regions across the world. Older adults are more likely to be diabetic and are further anticipated to develop diabetic foot ulcers and chronic wounds that can severely impact the quality of life. Therefore, with the growing aging population, the demand for advanced diabetic foot ulcer treatments will continue to increase in the coming years.

Asia Pacific Diabetic Foot Ulcer Market Overview

Diabetic foot disease is one of the leading causes of amputation among the population of Asia Pacific. Diabetic foot disease is Australia's leading cause of amputation and is among the top 20 causes of hospital admissions. As per Diabetic Feet Australia, in 2023, it has been estimated that nearly 300,000 Australians are at risk of developing diabetic foot disease, and 50,000 people live with it. Similarly, according to a study published in 2023 in Wiley Online Library, diabetic foot disease in China is as high as 30% among the diabetic population. Thus, the prevalence of diabetic foot disease in the region will drive the market growth in the upcoming years.

Market players in Asia Pacific are actively developing treatment options for diabetic foot ulcers. For instance, Cannenta, an Australia-based biotechnology company, is engaged in the development of advance wound care therapies for diabetic foot ulcers. In March 2021, Cynata Therapeutics Limited, an Australian clinical-stage stem cell and regenerative medicine company, collaborated with TekCyte Pty Ltd. for the commercial development of Cynata's mesenchymal stem cells product for diabetic foot ulcers. Therefore, the increasing prevalence of diabetes, rising cases of diabetic foot disease, and initiatives by market players are expected to boost the market growth in Asia Pacific.

Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Diabetic Foot Ulcer Market Segmentation

Based on treatment type, the Asia Pacific diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held a larger share in 2022.

Based on ulcer type, the Asia Pacific diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held a larger share in 2022.

Based on infection severity, the Asia Pacific diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held a larger share in 2022.

Based on end user, the Asia Pacific diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held a larger share in 2022.

Based on country, the Asia Pacific diabetic foot ulcer market is segmented into China, South Korea, Japan, Australia, India, and the Rest of Asia Pacific. China dominated the Asia Pacific diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Molnlycke Health Care AB, MiMedx Group Inc, and URGO Medical Australia Pty Ltd are some of the leading companies operating in the Asia Pacific diabetic foot ulcer market.

Product Code: BMIRE00029572

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Diabetic Foot Ulcer Market Landscape

4.1 Overview

5. Asia Pacific Diabetic Foot Ulcer Market - Key Industry Dynamics

5.1 Market Drivers:
- 5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
- 5.1.2 Surge in Geriatric Population
5.2 Market Restraints
- 5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
- 5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
- 5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:

6. Diabetic Foot Ulcer Market - Asia Pacific Market Analysis

6.1 Asia Pacific Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - by Treatment Type

7.1 Overview
7.2 Asia Pacific Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
- 7.3.1 Overview
- 7.3.2 Advanced Wound Care Dressings: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Alginate Dressings
  - 7.3.3.1 Overview
  - 7.3.3.2 Alginate Dressings: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Hydrofiber Dressings
  - 7.3.4.1 Overview
  - 7.3.4.2 Hydrofiber Dressings: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Foam Dressings
  - 7.3.5.1 Overview
  - 7.3.5.2 Foam Dressings: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Collagen Dressing
  - 7.3.6.1 Overview
  - 7.3.6.2 Collagen Dressing: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.7 Film Dressing
  - 7.3.7.1 Overview
  - 7.3.7.2 Film Dressing: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.8 Other Dressings
  - 7.3.8.1 Overview
  - 7.3.8.2 Other Dressing: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
- 7.4.1 Overview
- 7.4.2 Biologics: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Growth Factors
  - 7.4.3.1 Overview
  - 7.4.3.2 Growth Factors: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Skin Graft
  - 7.4.4.1 Overview
  - 7.4.4.2 Skin Graft: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
- 7.5.1 Overview
- 7.5.2 Therapy Device: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5.3 Negative Pressure Wound Therapy
  - 7.5.3.1 Overview
  - 7.5.3.2 Negative Pressure Wound Therapy: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5.4 Ultrasound Therapy
  - 7.5.4.1 Overview
  - 7.5.4.2 Ultrasound Therapy: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Ulcer Type

8.1 Overview
8.2 Asia Pacific Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
- 8.3.1 Overview
- 8.3.2 Neuropathic Ulcers: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
- 8.4.1 Overview
- 8.4.2 Ischemic Ulcers: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
- 8.5.1 Overview
- 8.5.2 Neuro-ischemic Ulcers: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Infection Severity

9.1 Overview
9.2 Asia Pacific Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
- 9.3.1 Overview
- 9.3.2 Mild: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.3 Moderate: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.4 Severe: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By End User

10.1 Overview
10.2 Asia Pacific Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgical Centers: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
- 10.5.1 Overview
- 10.5.2 Home Care: Asia Pacific Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

11. Diabetic Foot Ulcer Market - Asia Pacific Country Analysis

11.1 Asia Pacific Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
- 11.1.1 Overview
  - 11.1.1.1 Asia Pacific Diabetic Foot Ulcer Market by Country
  - 11.1.1.2 China
    - 11.1.1.2.1 China Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.2.2 China Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.2.3 China Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.2.3.1 China: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.2.3.2 China: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.2.3.3 China: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.2.4 China Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.2.5 China Diabetic Foot Ulcer Market, by End User
  - 11.1.1.3 Japan
    - 11.1.1.3.1 Japan Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.3.2 Japan Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.3.3 Japan Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.3.3.1 Japan: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.3.3.2 Japan: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.3.3.3 Japan: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.3.4 Japan Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.3.5 Japan Diabetic Foot Ulcer Market, by End User
  - 11.1.1.4 India
    - 11.1.1.4.1 India Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.4.2 India Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.4.3 India Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.4.3.1 India: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.4.3.2 India: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.4.3.3 India: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.4.4 India Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.4.5 India Diabetic Foot Ulcer Market, by End User
  - 11.1.1.5 Australia
    - 11.1.1.5.1 Australia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.5.2 Australia Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.5.3 Australia Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.5.3.1 Australia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.5.3.2 Australia: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.5.3.3 Australia: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.5.4 Australia Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.5.5 Australia Diabetic Foot Ulcer Market, by End User
  - 11.1.1.6 South Korea
    - 11.1.1.6.1 South Korea Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.6.2 South Korea Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.6.3 South Korea Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.6.3.1 South Korea: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.6.3.2 South Korea: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.6.3.3 South Korea: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.6.4 South Korea Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.6.5 South Korea Diabetic Foot Ulcer Market, by End User
  - 11.1.1.7 Rest of Asia Pacific
    - 11.1.1.7.1 Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.7.2 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.7.3 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.7.3.1 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.7.3.2 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.7.3.3 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.7.4 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.7.5 Rest of Asia Pacific Diabetic Foot Ulcer Market, by End User

12. Asia Pacific Diabetic Foot Ulcer Market Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Asia Pacific Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Asia Pacific Diabetic Foot Ulcer Market - Key Company Profiles

13.1 Convatec Group Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 3M Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Coloplast AS
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Smith & Nephew Plc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 B. Braun SE
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Molnlycke Health Care AB
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 MiMedx Group Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 URGO MEDICAL Australia Pty Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Medline Industries LP
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Organogenesis Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms